Estrogen Replacement in Women of Fertile Years with Hypopituitarism
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: What form of estrogen to prescribe a young hypopituitary woman with gonadal failure remains an open question despite evidence that oral estrogen therapy induces GH resistance and an increase in fat mass. METHODS: Using an international surveillance study of hypopituitary patients, we examined two questions: 1) What estrogen is prescribed to young women of fertile years with hypopituitarism? 2) Is there a difference in body composition or IGF-I levels dependent on the type of estrogen prescribed? RESULTS: Six hundred twenty-eight GH-deficient women, aged 18-50 yr, were identified. Three hundred thirteen had normal gonadal function, and 315 were receiving estrogen therapy; of these 14% were using transdermal estradiol, and 86% were taking an oral estrogen preparation (38% oral estradiol, 18% conjugated estrogens, and 30% ethinyl estradiol in the oral contraceptive). There was no difference in weight, waist/hip ratio, or body composition between the women taking different estrogen therapies. However, if the oral estrogen groups were combined, they showed less change in waist and hip measurement and had a greater waist/hip ratio after 1 yr of GH treatment compared with patients with normal gonadal function (0.85 vs. 0.83; P = 0.022). Patients taking ethinyl estradiol had lower age-adjusted IGF-I sd scores and required almost twice the GH dose to achieve an IGF-I sd score that remained lower than patients with normal gonadal function and patients receiving transdermal estradiol. CONCLUSIONS: 1) The majority of women of fertile years with hypo-pituitarism take oral estrogen replacement therapy. 2) Waist/hip ratio was greater in women taking oral estrogens, and there is indirect evidence that oral estrogens reduce the action of GH on fat mass. 3) Patients using the oral contraceptive had lower IGF-I levels and required twice the GH dose compared with patients receiving transdermal estradiol.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GC deficiency induces impaired free renal water clearance, resulting in the masking of polyuria in DI (200).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [200]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., et al. (2002) · JAMA · doi:10.1001/jama.288.1.49 · Cited by 1,930
Grady, D., Wenger, N. K., Herrington, D., Khan, S., Furberg, C., Hunninghake, D., Vittinghoff, E., Hulley, S., & for the Heart and Estrogen/progestin Replacement Study Research Group (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00002 · Cited by 715
Kaaks, R. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.19.1592 · Cited by 653
Juul, A., Scheike, T., Davidsen, M., Gyllenborg, J., & Jørgensen, T. (2002) · Circulation · doi:10.1161/01.cir.0000027563.44593.cc · Cited by 640
Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., & Wu, X. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.151 · Cited by 554
Estrogen Regulation of Growth Hormone Action
Leung, K.-C., Johannsson, G., Leong, G. M., & Ho, K. K. Y. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0035 · Cited by 542
WEISSBERGER, A. J., HO, K. K. Y., & LAZARUS, L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-374 · Cited by 514
Biologic effects of transdermal estradiol
Chetkowski, R., Meldrum, D., & Steingold, K. (1987) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(87)90325-0 · Cited by 467
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Mortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
Schneider, H. J., Aimaretti, G., Kreitschmann-Andermahr, I., Stalla, G.-K., & Ghigo, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60673-4 · Cited by 336
Holmer, H., Ekman, B., Björk, J., Nordstöm, C.-H., Popovic, V., Siversson, A., & Erfurth, E.-M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0449 · Cited by 79
Oral contraceptive use and bone density in adolescent and young adult women
Scholes, D., Ichikawa, L., LaCroix, A. Z., Spangler, L., Beasley, J. M., Reed, S. D., & Ott, S. M. (2009) · Contraception · doi:10.1016/j.contraception.2009.07.001 · Cited by 74
Cardiovascular risk factors in hypopituitary GH-deficient adults
Verhelst, J., & Abs, R. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0291 · Cited by 70
Fracture Incidence in GH-Deficient Patients on Complete Hormone Replacement Including GH
Holmer, H., Svensson, J., Rylander, L., Johannsson, G., Rosén, T., Bengtsson, B.-Å., Thorén, M., Höybye, C., Degerblad, M., Bramnert, M., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070811 · Cited by 66
“worthy that IGF-I production in the liver is impaired by oral estrogens, also shown by a somewhat lower SDS IGF-I level among CO GHD women, and enhanced by testosterone.((35,36)) Thus, a more likely explanation of the increased fracture risk in CO GHD women is estrogen insufficiency and an interaction between oral est…”
BackgroundSex steroids and the GH axis: implications for the management of hypopituitarism
Birzniece, V., & Ho, K. K. Y. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.03.003 · Cited by 65
Gutiérrez, L. P., Kołtowska‐Häggström, M., Jönsson, P. J., Mattsson, A. F., Svensson, D., Westberg, B., & Luger, A. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1510 · Cited by 64
Self-citationOvarian failure following cancer treatment: current management and quality of life
Absolom, K. L., Eiser, C., Turner, L., Ledger, W. J., Ross, R. J. M., Davies, H., Coleman, R., Hancock, B. W., Snowden, J. A., Greenfield, D., et al. (2008) · Human Reproduction · doi:10.1093/humrep/den285 · Cited by 63
Self-citationExcess mortality in women with pituitary disease: a meta‐analysis
Nielsen, E. H., Lindholm, J., & Laurberg, P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02947.x · Cited by 58
Pituitary Physiology and Diagnostic Evaluation
Melmed, S. K., Kleinberg, D. L., & Ho, K. K. Y. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00008-0 · Cited by 64
Filipsson, H., & Johannsson, G. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0319 · Cited by 50
Sonnet, E., Lacut, K., Roudaut, N., Mottier, D., Kerlan, V., & Oger, E. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02783.x · Cited by 44
MECHANISMS IN ENDOCRINOLOGY: Paracrine and endocrine control of the growth hormone axis by estrogen
Birzniece, V., & Ho, K. K. Y. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0155 · Cited by 41
Metabolic Syndrome in Hypopituitarism
Miljić, D., & POPOVIC, V. M. (2018) · Frontiers of hormone research · doi:10.1159/000485997 · Cited by 42
Pituitary Physiology and Diagnostic Evaluation
Kaiser, U. B., & Ho, K. K. Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00008-3 · Cited by 49
Hormone replacement therapy and the adolescent
DiVasta, A. D., & Gordon, C. M. (2010) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32833e4a35 · Cited by 38
Davenport, M. L. (2006) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2006.04.002 · Cited by 39
Phelan, N., Conway, S. H., Llahana, S., & Conway, G. S. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04277.x · Cited by 34
Hypopituitarism and Central Diabetes Insipidus
Devin, J. K. (2012) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2012.06.001 · Cited by 33
The physiology of growth hormone (GH) in adults: translational journey to GH replacement therapy
Ho, K. K. Y., O’Sullivan, A., & Burt, M. G. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0197 · Cited by 32
Hormone Replacement Therapy for the Adolescent Patient
DiVasta, A. D., & Gordon, C. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1429.012 · Cited by 27
Wilson, J. R., Utz, A. L., & Devin, J. K. (2015) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2015.12.005 · Cited by 26
Do nothing but observe microprolactinomas: when and how to replace sex hormones?
Bonert, V. S. (2020) · Pituitary · doi:10.1007/s11102-020-01039-x · Cited by 44
Courtillot, C., Baudoin, R., Du Souich, T., Saatdjian, L., Tejedor, I., Pinto, G., Léger, J., Polak, M., Golmard, J.-L., Touraine, P., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0572 · Cited by 20
Prevalence and treatment of central hypogonadism and hypoandrogenism in women with hypopituitarism
Olivius, C., Landin‐Wilhelmsen, K., Olsson, D. S., Johannsson, G., & Tivesten, Å. (2018) · Pituitary · doi:10.1007/s11102-018-0895-1 · Cited by 18
Anterior pituitary hormone replacement therapy—a clinical review
Auernhammer, C. J., & Vlotides, G. (2007) · Pituitary · doi:10.1007/s11102-007-0001-6 · Cited by 17
Lessons Learned from 15 Years of KIMS and 5 Years of ACROSTUDY
Luger, A., Feldt‐Rasmussen, U., Abs, R., Gaillard, R. C., Buchfelder, M., Trainer, P. J., & Brue, T. C. (2011) · Hormone Research in Paediatrics · doi:10.1159/000329156 · Cited by 13
Self-citationCarmichael, J. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00010-6 · Cited by 14
The Pituitary Gland and Age-Dependent Regulation of Body Composition
van Beek, A. P., Wolffenbuttel, B. H. R., Runge, E., Trainer, P. J., Jönsson, P., & Kołtowska‐Häggström, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2506 · Cited by 15
Self-citationPatching up a better pill for GH-deficient women
Birzniece, V., & Ho, K. K. Y. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.9 · Cited by 12
Managing Estrogen Therapy in the Pituitary Patient
Shoung, N., & Ho, K. K. Y. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad051 · Cited by 11
GH deficiency in cancer survivors in the transition age: diagnosis and therapy
Sbardella, E., Crocco, M., Feola, T., Papa, F., Puliani, G., Gianfrilli, D., Isidori, A. M., & Grossman, A. B. (2020) · Pituitary · doi:10.1007/s11102-020-01052-0 · Cited by 10
Chandrakasan, S., Sood, S., Ham, S. D., Moltz, K. C., Frey, M. J., & Rajpurkar, M. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.22937 · Cited by 10
Carmichael, J. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10010-0 · Cited by 8
Donald, D. M., McDonnell, T., O’Reilly, M., & Sherlock, M. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09897-7 · Cited by 8
Hypopituitarism and Growth Hormone Deficiency
Burt, M. G., & Ho, K. K. Y. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00011-1 · Cited by 9
Androgen Replacement Therapy in Androgen-Deficient Women with Hypopituitarism
Zang, H., & Davis, S. R. (2008) · Drugs · doi:10.2165/00003495-200868150-00001 · Cited by 7
Varlamov, E. V., & Fleseriu, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00019-6 · Cited by 6
Faria, M. D. S., Nascimento, G. C., Faria, A. M., & Martins, M. R. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_7 · Cited by 2
Ilovayskaya, I., & Zektser, V. (2024) · Endocrine · doi:10.1007/s12020-024-03872-7 · Cited by 2
Adult Growth Hormone Deficiency
Vaughan, T. B., Riley, K. O., & Blevins, L. S. (2013) · Wiley eBooks · doi:10.1002/9781118559406.ch5 · Cited by 2
Uncertainties in endocrine substitution therapy for central endocrine insufficiencies
Erfurth, E. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00028-9 · Cited by 2
Growth Promotion in Turner Syndrome
Rosenbloom, A. L., & Fudge, E. B. (2012) · Hormone Research in Paediatrics · doi:10.1159/000337788 · Cited by 1
Ilovayskaya, I., Zektser, V., Ильин, А. В., Гончаров, Н. П., & Dedov, I. I. (2010) · Obesity and metabolism · doi:10.14341/2071-8713-5279 · Cited by 1
Substitutionstherapie bei Wachstumshormonmangel
Luger, A. (2007) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
Tanna, A., Madula, R., Sandhu, H., Powrie, J., Thomas, S., Breen, L., Brackenridge, A., & Carroll, P. (2011)
Hypogonadotropic hypogonadism in women: treatment options
Greenman, Y. (2013) · Reviews in Endocrinology and Metabolism · doi:10.11138/rem/2013.1.2.062
Effects of estrogen therapy in young women with hypopituitarism
Lofthouse, M. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0084
Endocrine Issues Related to Stereotactic Radiosurgery in the Vicinity of the Pituitary Gland
Blevins, L. S. (2010) · Radiosurgery · doi:10.1159/000288735
GH Replacement Therapy in GH-Deficient Adults
Luger, A. (2006) · Journal für Kardiologie (Krause & Pachernegg GmbH)
(2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32802e6d87
Hypopituitarism and Growth Hormone Deficiency
Lee, P., & Ho, K. K. Y. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00013-7 · Cited by 2
Faria, M. D. S., Nascimento, G. C., Faria, A. M., & Martins, M. R. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8684-8_8
Ilovayskaya, I., Ledneva, A. S., & Zektser, V. (2023) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20232306163
Holmer, H. (2007) · Lund University Publications (Lund University)
Metadata
- Authors
- Mah, P. M., Webster, J., Jönsson, P., Feldt-Rasmussen, U., Koltowska-Häggström, M., & Ross, R. J. M.
- Affiliations
- University of Sheffield (GB)
- Pfizer (Sweden) (SE)
- Uppsala University (SE)
- ORCID
- Ross, R. J. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-11
- Volume
- 90
- Issue
- 11
- Pages
- 5964-5969
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2105479197
- Semantic Scholar
- 79a7b8d1ea4af92874ed067765f3e26e367214e9
- Cited by
- 57
- References
- 31
- Citations by year
- 2024: 2 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 2 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 4 · 2012: 3
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- estrogen replacement therapy, hypopituitarism, growth hormone deficiency, young women, transdermal estradiol, oral estrogen, ethinyl estradiol, oral contraceptives, insulin-like growth factor I, body composition, waist-to-hip ratio, fat mass, growth hormone dose
- MeSH terms
- Adolescent, Adult, Body Composition, Body Weight, Female, Humans, Hypopituitarism, Insulin-Like Growth Factor I, Middle Aged, Growth Hormone, Estrogen Replacement Therapy, Body Mass Index, Waist-Hip Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.